The first six companies enter the Deep Tech Lab - Quantum start-up accelerator at BioInnovation Institute (BII) to unlock the potential in quantum science
The Lifebit CloudOS will be employed to create a Federate Trusted Research Environment within the center’s supercomputing cluster to handle data management.
Danish analytical technology specialist Foss has reported a sharp
increase in organic growth in 2004, helped in part by the merger of
two of Foss subsidiaries, and the introduction of 10 new products
for the world market, reports...
Lactose specialist Borculo Domo has teamed up with Univar to ramp
up its presence in the Scandinavian pharmaceutical market, part of
a concerted effort to improve its standing internationally.
Faced with a raft of consolidation in the market for generic
pharmaceuticals, Germany's Merck KGaA has entered the fray with an
agreement to acquire most of NM Pharma, the Scandinavian generics
business of top drugmaker Pfizer.
Danish pharmaceutical companies increased their sales to overseas
countries by 20 per cent in the first four months of this year
compared with the same period of 2002, according to Invest In
Denmark.
Sweden's Amarin Development has been commissioned by GEA
Farmaceutisk Fabrik, a Danish subsidiary of German pharmaceutical
company HEXAL, to develop a formulation of one of its candidate
compounds.
The European Federation of Biotechnology (EFB) is setting up a
trade office in Aarhus, Denmark for its activities in innovation
and functional genomics, reports Biotech Denmark on its website.
